Principal Financial Group
AMPE

Principal Financial Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Principal Financial Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-123
Closed -$17K – 2706
2022
Q1 		$17K Buy
123
+8
+7% +$1.17K ﹤0.01% 2529
2021
Q4 		$20K Sell
115
-23
-17% -$8.58K ﹤0.01% 2513
2021
Q3 		$69K Buy
138
+37
+37% +$17.2K ﹤0.01% 2523
2021
Q2 		$51K Buy
+101
New +$54.2K ﹤0.01% 2570
2016
Q4 		– Sell
-33
Closed -$7K – 2259
2016
Q3 		$7K Buy
+33
New +$9.25K ﹤0.01% 2164
2014
Q4 		– Sell
-45
Closed -$48K – 2231
2014
Q3 		$48K Buy
+45
New +$75.8K ﹤0.01% 2188
2014
Q2 		– Sell
-52
Closed -$100K – 2328
2014
Q1 		$100K Hold
52
– – ﹤0.01% 2230
2013
Q4 		$112K Buy
+52
New +$123K ﹤0.01% 2235

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group's AMPE Position: Q2 2022 in Review

Principal Financial Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 123 shares — an estimated $17K sold.

Principal Financial Group first reported a position in AMPE in Q4 2013 and held it in 8 quarters. The position peaked at $112K in Q4 2013. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Principal Financial Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 123 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $17K.
  • Principal Financial Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 8 quarters.
  • Principal Financial Group's Ampio Pharmaceuticals Inc. position peaked at $112K in Q4 2013.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.